Completely resected stage IIIA non-small cell lung cancer: The significance of primary tumor location and N2 station

被引:94
|
作者
Ichinose, Y
Kato, H
Koike, T
Tsuchiya, R
Fujisawa, T
Shimizu, N
Watanabe, Y
Mitsudomi, T
Yoshimura, M
Tsuboi, M
机构
[1] Kyushu Natl Canc Ctr, Dept Chest Surg, Minami Ku, Fukuoka 8111395, Japan
[2] Tokyo Med Univ, Tokyo, Japan
[3] Niigata Canc Ctr Hosp, Niigata, Japan
[4] Natl Canc Ctr Hosp, Tokyo, Japan
[5] Chiba Univ, Sch Med, Chiba 280, Japan
[6] Okayama Univ, Sch Med, Okayama 700, Japan
[7] Kanazawa Univ, Sch Med, Kanazawa, Ishikawa 920, Japan
[8] Aichi Canc Ctr Hosp, Aichi, Japan
来源
关键词
D O I
10.1067/mtc.2001.116473
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The number of N2 stations (single vs multiple N2 stations) is an important prognostic factor in patients with completely resected stage IIIA-N2 non-small cell lung cancer. However, the significance of both the N2 station(s) actually involved and the primary tumor location remains unclear. Methods: The database was built with the use of a questionnaire survey on the survival of patients with pathologic stage IIIA-N2 non-small cell lung cancer completely resected between January 1992 and December 1993. The survey was performed by the Japan Clinical Oncology Group as of July 1999. The data include information on the survival and N2 stations of 402 patients. Results: A, frequently metastasized single N2 station was the lower pretracheal station in primary tumors in the right upper lobe, the subaortic station in the left upper lobe, and the subcarinal station in the right middle or lower lobe and the left lower lobe. In multiple N2 stations, the frequency of metastasis of the N2 station observed in a single N2 station was as high as 72% to 89%, and one or two other frequently metastasized stations were added to each group. Regarding the survival of patients with a primary tumor in each lobe except for the left lower lobe, a single N2 station resulted in a significantly better survival than did multiple N2 stations. Furthermore, the overall survivals classified according to each primary site showed a significant difference among the four primary sites (P =.04). Conclusions: The primary tumors in each lobe showed a prevalence of N2 station(s). The number of N2 stations is a good prognosticator except in patients with a primary tumor in the left lower lobe. In addition, the site of a primary tumor itself is also considered to influence the survival of the patients.
引用
收藏
页码:803 / 808
页数:6
相关论文
共 50 条
  • [31] Post-Operative Radiotherapy in completely resected Non-Small Cell Lung Cancer and N2 involvement
    Pires, A. M.
    Figueiredo, T.
    Conde, S.
    Ferreira, C.
    Laranja, A.
    de Castro, B.
    Sousa, F.
    Sarandao, S.
    Cardia, J.
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S955 - S956
  • [32] Prognosis and Clinicopathologic Characteristics of Skip N2 Metastasis in Completely Resected Non-Small Cell Lung Cancer
    Tsuboi, T.
    Eriguchi, D.
    Nemoto, D.
    Samejima, J.
    Nagashima, T.
    Ito, H.
    Nakayama, H.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S551 - S551
  • [33] Adjuvant chemotherapy in completely resected stage III-N2 non-small cell lung cancer
    Wang, S.
    Ou, W.
    Sun, H.
    Yang, H.
    Ye, X.
    Fang, Q.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [34] Trimodal therapy and surgical approaches in stage IIIA/N2 non-small cell lung cancer
    Hu, Pin-Ching
    Huang, Jing-Yang
    Cheng, Ya-Fu
    Cheng, Ching-Yuan
    Huang, Chang-Lun
    Hung, Wei-Heng
    Wang, Bing-Yen
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [35] The Differential Impact of Postoperative Radiation Therapy for Completely Resected Stage IIIA (N2) Non-Small Cell Lung Cancer: Based on the Risk Prediction Model for Locoregional Recurrence
    Feng, W.
    Fu, X. L.
    Cai, X. W.
    Zhang, Q.
    Yu, W.
    Chen, H. Q.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : S69 - S69
  • [36] Is postoperative radiotherapy effective in patients with completely resected pathologic stage IIIA(N2) non-small cell lung cancer? High-risk populations should consider it
    Zhang, Shu-Xian
    Zhang, Chen-Chen
    Hou, Run-Ping
    Cai, Xu-Wei
    Liu, Jun
    Yu, Wen
    Zhang, Qin
    Guo, Jin-Dong
    Wang, Chang-Lu
    Li, Hong-Xuan
    Zhu, Zheng-Fei
    Fu, Xiao-Long
    Feng, Wen
    CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2025, 50
  • [37] Meta-analysis of prognostic factors of completely resected pathologic N2 stage IIIA non-small cell lung cancer including 11,384 patients
    Zhan, X.
    Li, N.
    ANNALS OF ONCOLOGY, 2018, 29 : 490 - 490
  • [38] Prognostic Value of Preoperative N Subcategories in Patients with Stage IIIA N2 Non-Small Cell Lung Cancer
    Oh, Na Eun
    Choe, Jooae
    Yun, Jae Kwang
    Ji, Wonjun
    Kim, Seonok
    Chae, Eun Jin
    Lee, Sang Min
    Seo, Joon Beom
    RADIOLOGY-CARDIOTHORACIC IMAGING, 2024, 6 (04):
  • [39] Patterns of Local-Regional Failure in Completely Resected Stage IIIa (N2) Non-Small Cell Lung Cancer Patients: Implications for Postoperative Radiation Therapy Target Volumes
    Feng, W.
    Fu, X.
    Hua, Y.
    Yang, H.
    Zhu, Z.
    Cai, X.
    Jiang, G.
    Zhang, Y.
    Xiang, J.
    Chen, H.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S521 - S521
  • [40] Feasibility and Safety of the Clinical Target Volume Design for Postoperative Radiation Therapy in Completely Resected Stage IIIA(N2) Non-Small Cell Lung Cancer: A Prospective Validation Study
    Feng, W.
    Zhang, Q.
    Yu, W.
    Cai, X. W.
    Fu, X. L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E445 - E445